Freedom Investment Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-3,787
| Closed | -$351K | – | 842 |
|
2024
Q2 | $351K | Sell |
3,787
-71
| -2% | -$6.58K | 0.03% | 530 |
|
2024
Q1 | $366K | Sell |
3,858
-98
| -2% | -$9.3K | 0.03% | 531 |
|
2023
Q4 | $353K | Buy |
+3,956
| New | +$353K | 0.03% | 540 |
|
2023
Q3 | – | Sell |
-16,316
| Closed | -$1.36M | – | 765 |
|
2023
Q2 | $1.36M | Sell |
16,316
-4,250
| -21% | -$354K | 0.15% | 168 |
|
2023
Q1 | $1.57M | Sell |
20,566
-14,693
| -42% | -$1.12M | 0.18% | 151 |
|
2022
Q4 | $2.93M | Buy |
+35,259
| New | +$2.93M | 0.33% | 67 |
|
2022
Q3 | – | Sell |
-19,330
| Closed | -$1.44M | – | 785 |
|
2022
Q2 | $1.44M | Buy |
+19,330
| New | +$1.44M | 0.15% | 180 |
|
2022
Q1 | – | Sell |
-19,466
| Closed | -$2.18M | – | 962 |
|
2021
Q4 | $2.18M | Buy |
+19,466
| New | +$2.18M | 0.16% | 165 |
|
2020
Q3 | – | Sell |
-35,856
| Closed | -$4.01M | – | 605 |
|
2020
Q2 | $4.01M | Buy |
+35,856
| New | +$4.01M | 0.44% | 48 |
|